VRAX
Virax Biolabs Group Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$2.54
+0.40%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$1.75
- Revenue estimate
- $12.4K
Latest reported
- Last report date
- Dec 2, 2025
- EPS actual
- -$0.49
- EPS estimate
- —
- Revenue actual
- $1.6K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Dec 2, 2025 | — | -$0.49 | — | $1.6K |
| Nov 19, 2024 | — | -$0.89 | — | — |
| Aug 20, 2024 | — | -$1.71 | — | $79.9K |
| Aug 12, 2022 | — | -$1.02 | — | -$92.9K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026